Parathyroid Neuroendocrine Tumor Located in the Trachea of one Bitch

Authors

DOI:

https://doi.org/10.22456/1679-9216.140629

Keywords:

tracheal tumors, neuron-specific enolase, calcitonin

Abstract

Background: Neuroendocrine tumors make up a family of neoplasms that can be found in different tissues and organs, including those that do not usually contain neuroendocrine cells. These tumors are diagnosed based on histopathological examination and the presence of neuroendocrine markers in the immunohistochemical examination, including neuron-specific enolase (NSE), chromogranin A and synaptophysin. This paper describes the occurrence of a parathyroid neuroendocrine tumor located in the lumen of the trachea of one bitch, and characterizes its clinical evolution. 

Case: A 10-year-old bitch of Siberian Husky breed, suffering for a week from reported symptoms of coughing and dyspnea, was treated at the  private Veterinary Hospital Petmania, São Luís, MA, Brazil. After a clinical evaluation, additional tests were requested, including a chest X-ray, complete blood count, assessment of renal (urea, creatinine) and liver function (albumin, ALT, AST, alkaline phosphatase), and abdominal ultrasound, all of which fell within the normal limits. The chest X-ray revealed a 2.1 cm x 1.2 cm formation in the region of the thoracic trachea. An electrocardiogram was performed, but revealed no changes. The patient underwent a tracheoscopy for excisional biopsy of the mass, using a polyp forceps. The biopsy material was subjected to histopathological and immunohistochemical analysis, which confirmed that it was a parathyroid neuroendocrine tumor containing immunoreactive neuron-specific enolase and calcitonin. A chest tomography was requested, but was not performed. After a parathyroid neuroendocrine tumor was diagnosed, additional complementary tests were carried out to examine changes in the thyroid and parathyroid, which included measurement of ionized calcium, post-dialysis free T4, total T4, sodium, chlorine, potassium and cervical ultrasound. These tests indicated mild hypercalcemia and hyponatremia. The patient was monitored clinically for 30 days, after which the symptoms of dyspnea and cough returned. The patient was subjected to tracheoscopy, which revealed a new tumor growth in the same location. Soon thereafter, the patient died. 

Discussion: Parathyroid neuroendocrine tumors are rare in dogs, and no reports were found of this type of neoplasm located in the trachea. The patient in this case report presented a mass in the intraluminal portion of the thoracic trachea, which led to the manifestation of respiratory obstruction. Neuroendocrine tumors may develop in tissues that do not contain neuroendocrine cells, such as the trachea. Furthermore, malignant neoplasms have the characteristic of inducing the dissemination of tumor cells that can implant themselves in other tissues, although no neoplastic lesion was found other than in the trachea in the patient of this case report. The treatment of tracheal neoplasms involves surgical resection and tracheal anastomosis.  However, this is a complex surgical procedure, especially if it involves the intrathoracic trachea. In this patient, no surgical treatment was performed due to the rapid evolution of the disease and the lack of tomographic diagnosis for adequate surgical planning. Neuroendocrine tumors, albeit rare, have been described before in different anatomical locations in dogs. It is concluded that the neuroendocrine tumor of the patient in this case demonstrated an aggressive evolution with a poor prognosis and low survival rate after diagnosis. 

Keywords: tracheal tumors, neuron-specific enolase, calcitonin. 

Título: Tumor neuroendócrino de paratireóide localizado na traqueia de uma cadela 

Descritores: tumor traqueal, neuro enolase específica, calcitonina.

Downloads

Download data is not yet available.

Author Biography

Lygia Silva Galeno, Universidade Estadual do Maranhão (UEMA), São Luís-MA, Brasil

Programa de Pós-Graduação em Ciência Animal, Universidade Estadual do Maranhão (PPG-UEMA).

References

Campos M., Ducatelle R., Rutteman G., Kooistra H.S., Duchateau L., Rooster H., Peremans K. & Daminet S. 2014. Clinical, pathologic, and immunohistochemical prognostic factors in dogs with thyroid carcinoma, Journal of Veterinary Internal Medicine. 28(6): 1805-1813. DOI: 10.1111/jvim.12436.

De Nardi A.B. & Pascoli A.L.C.R. 2016. Neoplasias da Paratireóide. In: Daleck C.R & De Nardi A.B. (Eds). 2.ed. Oncologia em Cães e Gatos. Rio de Janeiro: Roca, pp.636-641.

Delellis R.A. 2001. The neuroendocrine system and its tumors: an overview. American Society for Clinical Pathology. 115: S5-S16. DOI: 10.1309/7GR5-L7YW-3G78-LDJ6.

Fischer S. & Asa S.L. 2008. Application of immunohistochemistry to thyroid neoplasms. Archives of Pathology & Laboratory Medicine. 139(1): 67-82. DOI: https://doi.org/10.5858/arpa.2014-0056-RA

Gould V.E., Lee I. & Warren W.H. 1988. Immunohistochemical Evaluation of Neuroendocrine Cells and Neoplasms of the Lung. Laboratory Investigation. 183(2): 200-213. DOI: https://doi.org/10.1016/S0344-0338(88)80047-5

Ichimata M., Nishiyama S., Matsuyam F., Fukazawa E., Harada K., Katayama R., Toshima A., Kagawa W., Yamagami T. & Kobayashi T. 2021. Long-term survival in a dog with primary hepatic neuroendocrine tumor treated with toceranib phosphate. The Journal Veterinary Medical Science. 83(10): 1554-1558. DOI: 10.1292/jvms.21-0254

Ito Y., Miyauchi A., Kakudo K., Hirokawa M., Kobayashi K. & Miya A. 2010. Prognostic Significance of Ki-67 Labeling Index in Papillary Thyroid Carcinoma. World Journal of Surgery. 34(12): 3015-3021. DOI: 10.1007/s00268-010-0746-3

Lucyshyn D.R., Knickelbein K.E., Hollingsworth S.R., Reilly C.M., Brust K.D., Visser L.C., Burge R., Willcox J.L. & Maggs D.J. 2021. Choroidal neuroendocrine neoplasia in a dog. Veterinary Ophthalmology. 24(3): 301-307. DOI: 10.1111/vop.12875.

Martano M., Boston S. & Morello E. 2012. Respiratory tract and thorax. In Kudnig ST. & Seguin B. (Eds). Veterinary Surgical Oncology. Hoboken: Wiley Blackwell, pp.273-328.

O’brien K.M., Bankoff B.J., Rosenstein P.K., Clendaniel D.C., Sánchez M.D. & Durham A.C. 2020. Clinical, histopathologic, and immunohistochemical features of 13 cases of canine gallbladder neuroendocrine carcinoma. Journal of Veterinary Diagnostic Investigation. 33(2): 294-299. DOI: 10.1177/1040638720978172.

Patnaik A.K., Ludwing L.L. & Erlandson R.A. 2002. Neuroendocrine carcinoma of the nasopharynx in a dog. Veterinary Pathology. 39(4): 496-500. DOI: 10.1354/vp.39-4-496.

Pugh E., Fonfara S., Appeby R., Comeua D., Minors S. & Singh A. 2022. Intrapericardial neuroendocrine tumour in a dog. Journal Veterinary Cardiology. 39: 63-68. DOI: 10.1016/j.jvc.2021.12.007.

Ramirez G.A., Altimira J. & Vilafranca M. 2015. Cartilaginous tumors of the larynx and trachea in the dog: literature review and 10 additional cases (1995-2014). Veterinary Pathology. 52(6): 1019-1026. DOI: 10.1177/0300985815579997.

Rossi G., Magi G.E., Tarantino C., Taccini E., Mari S., Pengo G. & Renzoni G. 2007. Tracheobronchial neuroendocrine carcinoma in a cat. Journal of Comparative Pathology. 137(2-3): 165-168. DOI: 10.1016/j.jcpa.2007.06.003.

Schmechel D., Marangos PJ. & Brightman M. 1978. Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature. 276(5690): 834-836. DOI: 10.1038/276834a0.

Solcia E., Klöppel G. & Sobin L.H. 2000. Histological Typing of Endocrine Tumours. 2nd edn. Berlin: Springer-Verlag, pp.7-13.

Additional Files

Published

2025-02-24

How to Cite

Galeno, L. S., Barbalho Lima, T., Santos de Jesus, L. M., de Andrade Oliveira Cruz, T. N., Azevedo Carvalho, V. H., & Costa Araújo Dourado, A. V. (2025). Parathyroid Neuroendocrine Tumor Located in the Trachea of one Bitch. Acta Scientiae Veterinariae, 53. https://doi.org/10.22456/1679-9216.140629